- Home
- Wegovy
Blog
A just published study from JAMA Open Network that examined the health records of people with type 2 diabetes and opioid […]
The European Medicines Agency’s Committee for Medicinal Products is recommending an update to Novo Nordisk’s medication Wegovy’s (semaglutide 2.4 mg) […]
A new study released by the makers of the weight loss medication Wegovy (Semaglutide) finds that it reduced the occurrence of kidney problems by […]
Weight Loss Drugs & Depression and Anxiety According to research published by Epic Research weight loss drugs were linked to a lower […]
WEIGHT LOSS MEDICATIONS REDUCE COLON CANCER RISK Newly completed research published in the scientific journal JAMA Oncology (Journal of the […]
Exploring the Benefits of Semaglutide (Ozempic-Wegovy) Dementia is a condition with a significant and increasing impact on individuals and society. […]
Wegovy, Ozempic and Mounjaro Surging demand for drugmaker Novo Nordisk’s highly popular diabetes treatments Ozempic and Wegovy, now being used […]